We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
(+6.7%)
Cap. Flow
-$3.28B
Cap. Flow
% of AUM
-1.24%
Top 10 Holdings %
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.03B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$649M |
| 3 |
NVIDIA
NVDA
|
+$329M |
| 4 |
AT&T
T
|
+$316M |
| 5 |
Tesla
TSLA
|
+$313M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$474M |
| 2 |
CELG
Celgene Corp
CELG
|
+$421M |
| 3 |
Broadcom
AVGO
|
+$411M |
| 4 |
Netflix
NFLX
|
+$387M |
| 5 |
Apple
AAPL
|
+$372M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.51% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Chubb
CB
$135B
| $668M | 0.25% |
4,289,694
-77,698
| -2% | -$11.9M |
|
77
PNC Financial Services
PNC
$101B
| $662M | 0.25% |
4,148,717
-191,718
| -4% | -$28.8M |
|
|
78
Netflix
NFLX
$309B
| $661M | 0.25% |
20,425,110
-13,047,830
| -39% | -$387M |
|
79
Target
TGT
$67.4B
| $659M | 0.25% |
5,137,890
+363,988
| +8% | +$42.7M |
|
|
PPLI
80
People Inc
PPLI
$3.14B
| $658M | 0.25% |
14,772,032
-1,707,070
| -10% | -$68.8M |
|
|
81
Tesla
TSLA
$1.29T
| $655M | 0.25% |
23,498,160
+14,419,725
| +159% | +$313M |
|
82
Roper Technologies
ROP
$39.7B
| $651M | 0.25% |
1,838,452
-122,934
| -6% | -$42.5M |
|
83
Trane Technologies
TT
$106B
| $651M | 0.25% |
4,895,810
-196,027
| -4% | -$24.8M |
|
84
FirstEnergy
FE
$27.5B
| $649M | 0.25% |
13,354,000
-1,838,526
| -12% | -$87.9M |
|
85
Zimmer Biomet
ZBH
$18.4B
| $643M | 0.24% |
4,425,024
-63,751
| -1% | -$8.8M |
|
86
ConocoPhillips
COP
$142B
| $628M | 0.24% |
9,656,663
+3,103,199
| +47% | +$182M |
|
87
NXP Semiconductors
NXPI
$60.1B
| $622M | 0.24% |
4,885,156
+1,575,410
| +48% | +$183M |
|
88
Starbucks
SBUX
$121B
| $621M | 0.24% |
7,065,850
-575,709
| -8% | -$49.1M |
|
89
Northrop Grumman
NOC
$80.9B
| $621M | 0.24% |
1,805,206
+269,706
| +18% | +$94.8M |
|
90
RTX Corp
RTX
$300B
| $616M | 0.23% |
6,540,183
+468,724
| +8% | +$42.5M |
|
91
Elevance Health
ELV
$85.5B
| $611M | 0.23% |
2,022,680
+615,781
| +44% | +$169M |
|
92
CME Group
CME
$95.5B
| $608M | 0.23% |
3,028,571
-110,637
| -4% | -$22.7M |
|
93
L3Harris
LHX
$53.6B
| $602M | 0.23% |
3,040,373
+17,260
| +0.6% | +$3.46M |
|
94
Baxter International
BAX
$14.3B
| $600M | 0.23% |
7,169,424
+2,867,801
| +67% | +$237M |
|
95
Monster Beverage
MNST
$88.4B
| $593M | 0.23% |
18,676,228
+347,990
| +2% | +$10.2M |
|
96
Equinix
EQIX
$104B
| $587M | 0.22% |
1,005,414
-39,757
| -4% | -$22.3M |
|
97
IBM
IBM
$223B
| $580M | 0.22% |
4,525,410
-644,265
| -12% | -$83.7M |
|
98
Boston Scientific
BSX
$71.6B
| $571M | 0.22% |
12,628,024
+1,693,953
| +15% | +$70.9M |
|
99
Automatic Data Processing
ADP
$108B
| $560M | 0.21% |
3,287,377
-443,871
| -12% | -$73.5M |
|
|
SCHW
100
Charles Schwab
SCHW
$186B
| $560M | 0.21% |
11,764,473
+5,864,634
| +99% | +$259M |
|
Similar funds
VFT
Nuveen's Q4 2019 Portfolio in Review
As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
- Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
- Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
- Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
- Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
- Nuveen opened 118 new positions and closed 95 in Q4 2019.
- Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.
Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.